← Eichor
Condition: Paraganglioma Phaeochromocytoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Paraganglioma Phaeochromocytoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06041516Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
Phase 2 · 9 location(s) · Jazz Pharmaceuticals · NCT07282587In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
EARLY_Phase 1 · 1 location(s) · Heather Wachtel · NCT05636540Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00001238Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma
NA · 1 location(s) · Peking Union Medical College Hospital · NCT0728893118F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT05069220An Experimental Study of Belzutifan Impact on Catecholamine Metabolism
Phase 2 · 1 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT07680205Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendoc
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06427798"Receptor Radionuclide Therapy With 177Lu-DOTATOC
Phase 2 · 2 location(s) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT0604526018F-mFBG PET Imaging in the Evaluation of Pheochromocytoma
Phase N/A · 2 location(s) · First Affiliated Hospital of Zhejiang University · NCT0681374218F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06503146Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · 1 location(s) · Fudan University · NCT06683846Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Phase N/A · 3 location(s) · Universidad Nacional Autonoma de Mexico · NCT06523582Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Phase N/A · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT03160274Adrenal Tumors - Pathogenesis and Therapy
Phase N/A · 1 location(s) · University of Wuerzburg · NCT00669266Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial
Phase 2 · 1 location(s) · José Claudio Casali da Rocha · NCT07167329Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging
Phase N/A · 1 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT07195500Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treat
Phase 1/Phase 2 · 1 location(s) · Fundación de investigación HM · NCT06607692Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor
Phase 2 · 84 location(s) · Merck Sharp & Dohme LLC · NCT04924075The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma
Phase 4 · 1 location(s) · Seoul National University Hospital · NCT05702944Project: Every Child for Younger Patients With Cancer
Phase N/A · 278 location(s) · Children's Oncology Group · NCT02402244Diagnosis of Pheochromocytoma
Phase 1 · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT00004847Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid
Phase 1 · 3 location(s) · Anusha Kalbasi · NCT04119024Hereditary Pheochromocytoma Assessment of Tumour Immunologies
Phase N/A · 1 location(s) · Radboud University Medical Center · NCT06444607Natural History Study of Children and Adults With Medullary Thyroid Cancer
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01660984[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors,
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06479811HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/Phase 2 · 5 location(s) · Cancer Research UK · NCT05944237Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT03206060
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.